Perspectives: Every Presidential Candidate Should Prioritize Affordable Prescriptions; It’s Time To Reform 340B
Read recent commentary about pharmaceutical issues.
The independent source for health policy research, polling, and news.
4,461-4,480 of 113,033 results
Read recent commentary about pharmaceutical issues.
The botanical has been used for centuries in Southeast Asia, Bloomberg notes, but it's more commonly found in drinks and concentrates in the U.S., triggering the research effort. Separately, financial incentives for kidney donors; changing research standards on trans issues; and more.
Read recent pharmaceutical developments in KFF Health News' Prescription Drug Watch roundup.
Editorial writers tackle these public health issues.
The goal is to reduce the impact of incorrect diagnoses, or delayed ones, which can occur for many different reasons and seriously impact the safety of patient care. Among other news, New Hampshire’s attorney general demands answers from Exeter Hospital about plans to cut services.
Also, Sen. Bernie Sanders spoke up again about Ozempic's manufacturer Novo Nordisk, alleging that it can make and sell its weight loss drug for under $100 a month. Meanwhile, CNN notes that GLP-1 drugs in pill form are coming, and this may revolutionize weight loss treatments.
The respiratory virus is linked, in rare cases, to acute flaccid myelitis, which affects the nervous system. Meanwhile, flu deaths among kids for the 2023-24 season tied the U.S. record high of 199.
The policy initiative previously was proposed by President Joe Biden. Meanwhile, the U.S. House today is set to vote on funding the government. The Washington Post reports that it doesn't have enough support to pass.
The Democratic measure, which would have ensured federal protections to the fertility treatment, failed 51-44. The GOP bill, which focused on access to IVF, did not gain unanimous consent to pass. Meanwhile, AP and ProPublica report about pregnant women who have died since Roe v. Wade was overturned.
NPR reports that some researchers believe the data could show an even larger drop, beyond the 10.6% drop that CDC data shows, when federal surveys take stock of state-level improvements. Separately, more than a quarter of those in Baltimore know someone who fatally overdosed.
Even though cancer death rates have fallen, the report notes, moderate and light drinkers saw more cancer deaths than occasional drinkers.
Today's early morning highlights from the major news organizations.
Editorial writers examine these public health issues.
A multimedia reporting project from KFF Health News, Retro Report, and GBH's WORLD explores the impact of a 1942 lynching and a 2020 police shooting in the same rural Missouri community.
A paramedic convicted in the 2019 death of Elijah McClain has had his sentence reduced to probation. McClain died after police put him in a chokehold and paramedics injected him with sedatives. Among other news: Samaritan Health Services lays off 1% of its workforce.
CNN reports on a new study that maps brain changes during pregnancy. Also in research news: the chemical toll of food packaging on our bodies; microplastics at the base of the brain; and more.
The Meta-owned app will make accounts private for its users who are younger than 18. The company also will halt notifications during typical nighttime rest hours and limit sensitive content.
The measure, sponsored by Republican Sen. Susan Collins, was introduced after a mass shooting in Maine and would require the Army to take action using state crisis intervention laws. Separately, AP says police have increased use of Maine's "yellow flag" law to seize weapons.
The rapid infusion of the chemical, used in plastic products, into the fentanyl supply is raising significant concern among health researchers. Also: The Washington Post examines how Purdue's global counterparts are still profiting from the sale of opioids, and more.
Axios reports that multiple high-ranking GOP lawmakers said that if Donald Trump wins the election, Republicans might attempt to dismantle the popular price reductions over concerns about pharmaceutical innovation.
© 2026 KFF